Production of High-purity Radium-223 from Legacy Actinium-Beryllium Neutron Sources

Radium-223 is a short-lived alpha-particle-emitting radionuclide with potential applications in cancer treatment. Research to develop new radiopharmaceuticals employing 223Ra has been hindered by poor availability due to the small quantities of parent actinium-227 available world-wide. The purpose o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current radiopharmaceuticals 2012-06, Vol.5 (3), p.244-252
Hauptverfasser:	Soderquist, Chuck Z, McNamara, Bruce K, Fisher, Darrell R
Format:	Artikel
Sprache:	eng
Schlagworte:	Actinium actinium-227 Alpha emitters Alpha Particles - therapeutic use anion exchange Anion Exchange Resins Beryllium Humans Neoplasms - radiotherapy Neutrons NUCLEAR PHYSICS AND RADIATION PHYSICS Quality Control Radioactivity Radionuclide Generators Radiopharmaceuticals - chemical synthesis Radiopharmaceuticals - isolation & purification Radium - isolation & purification radium-223 thorium-227
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!